Rare disease patient organisations can steer or even lead in partnership with all other health stakeholders, including academia most of the work to map out the context of use (stages of disease, sub-populations, healthcare system) and concepts of interest
2,547 followers
2,547 followers
2,547 followers
2,547 followers